Nymox Pharmaceutical
(OTC) NYMXF
Nymox Pharmaceutical Financials at a Glance
Market Cap
$7.56M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.92M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-4.18 (Low)
Dividend
$0.00
Beta (Volatility)
-4.18 (Low)
Price
$0.08
Volume
4,752
Open
$0.07
Price
$0.08
Volume
4,752
Open
$0.07
Previous Close
$0.08
Daily Range
$0.07 - $0.08
52-Week Range
$0.03 - $0.15
Dividend
$0.00
Beta (Volatility)
-4.18 (Low)
Price
$0.08
Volume
4,752
Open
$0.07
Previous Close
$0.08
Daily Range
$0.07 - $0.08
52-Week Range
$0.03 - $0.15
NYMXF News
Whoa! What Just Happened to My Stock?
3 Stocks Shaking the Market
Hidden Stocks for High Returns
3 Stocks Shaking the Market
3 Stocks Shaking the Market
Low-Profile Stocks for High Returns
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nymox Pharmaceutical
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
Paul Averback, MD
Website
www.nymox.comHeadquarters
Nassau, BS
NYMXF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
63%
Return on Assets
-7%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.56M
Shares Outstanding
94.54M
Volume
4.75K
Short Interest
0.00%
Avg. Volume
14.37K
Financials (TTM)
Gross Profit
$1.00K
Operating Income
$4.28M
EBITDA
$4.26M
Operating Cash Flow
$2.60M
Capital Expenditure
$0.00
Free Cash Flow
$2.60M
Cash & ST Invst.
$74.00K
Total Debt
$0.00
Nymox Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$7.56M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$857.00K
+22.8%
EBITDA
$771.00K
+29.7%
Quarterly Fundamentals
Net Cash
$74.00K
+111.0%
Accounts Receivable
$27.00K
+170.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-6.87%
N/A
Return on Invested Capital
63.22%
N/A
Free Cash Flow
$717.00K
+27.6%
Operating Cash Flow
$717.00K
+27.4%